FGF2 and cancer: Reduced HSP27 protein expression in angiogenic cancer cells led to a low secretion level of pro-angiogenic factors (such as VEGF-A, VEGF-C, and basic fibroblast growth factor), which resulted in poorer proliferation and migration of cancer cells and effectively suppressed tumor growth and angiogenesis.